Using data from CGGA and TCGA, higher expression of PD-L2 was observed in higher glioma grades and IDH-wt gliomas and could predict an unfavorable prognosis of patients independent of other factors such as age, grade, IDH status and 1p/19q status. This evidence concerns the gene PDCD1LG2 and central nervous system cancer.